Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Research & Development: 2016-2019

Historic Research & Development for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $2.0 million.

  • Monopar Therapeutics' Research & Development rose 12.05% to $583,778 in Q4 2019 from the same period last year, while for Dec 2019 it was $2.0 million, marking a year-over-year increase of 24.16%. This contributed to the annual value of $2.0 million for FY2019, which is 10.94% up from last year.
  • According to the latest figures from FY2019, Monopar Therapeutics' Research & Development is $2.0 million, which was up 10.94% from $1.8 million recorded in FY2018.
  • Monopar Therapeutics' 5-year Research & Development high stood at $2.0 million for FY2019, and its period low was $280,355 during FY2016.
  • Its 3-year average for Research & Development is $1.6 million, with a median of $1.8 million in 2018.
  • Data for Monopar Therapeutics' Research & Development shows a peak YoY soared of 233.62% (in 2017) over the last 5 years.
  • Monopar Therapeutics' Research & Development (Yearly) stood at $280,355 in 2016, then spiked by 233.62% to $935,319 in 2017, then skyrocketed by 89.72% to $1.8 million in 2018, then climbed by 10.94% to $2.0 million in 2019.